Systemic Levels of Cystatin C in Critically Ill Patients at risk for Acute Renal Failure.

• Conditions: acute renal failure; renal failure; 10038430

• Registration Number: NL-OMON29748
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 600

Inclusion Criteria

Expected duration of mechanical ventilation > 48 hours and/or
Expected duration of stay in ICU > 72 hours
age > 18 years

Exclusion Criteria

Chronic renal replacement therapy before present admission
Plasmapheresis
High dose corticosteroids (> 5 mg/day)

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>ARF and ARF for which HF is started.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>None</p><br>